GO:0007023 post-chaperonin tubulin folding pathway: Protein Folding Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007023 describes the completion of alpha- and beta-tubulin folding that occurs after chaperonin-mediated partial folding and depends on a complex of tubulin folding cofactors.
• The pathway is mediated by cofactors including tubulin folding cofactor A (TBCA), which binds beta-tubulin and is structurally conserved from yeast to plants and humans.
• Cofactor A (TBCA) is a small, highly conserved protein whose crystal structures have been solved for yeast Rbl2p and human TBCA, revealing a dimeric alpha/beta fold that sequesters beta-tubulin.
• The pathway is essential for producing assembly-competent alpha/beta-tubulin heterodimers, the building blocks of microtubules.
• Dysregulation of tubulin folding cofactors has been linked to inflammatory and neurological conditions, including sepsis-associated encephalopathy in rat models.
• Research on this pathway uses structural biology, biochemical reconstitution, and CRISPR-based cell models to dissect cofactor function and disease relevance.
Description
The post-chaperonin tubulin folding pathway (GO:0007023) is the biological process that completes the folding of alpha- and beta-tubulin after they have been partially folded by chaperonins. This pathway is mediated by a complex of tubulin folding cofactors that ensure newly synthesized tubulin polypeptides attain their native, assembly-competent conformations. Because tubulin heterodimers are the fundamental building blocks of microtubules, this pathway is central to cytoskeletal dynamics, cell division, and intracellular transport. Researchers study GO:0007023 to understand how cells maintain tubulin homeostasis and how defects in folding cofactors contribute to disease. Structural and biochemical studies have revealed that cofactor A (TBCA) binds beta-tubulin and is conserved across species, including yeast, plants, and humans. This article integrates authoritative QuickGO data with verified PubMed literature to provide a research-grade overview of the pathway, its genes, and experimental approaches.
post-chaperonin tubulin folding pathway At A Glance
| GO ID | GO:0007023 |
|---|---|
| GO term | post-chaperonin tubulin folding pathway |
| Ontology | biological_process |
| Synonym | None |
| Definition | Completion of folding of alpha- and beta-tubulin; takes place subsequent to chaperonin-mediated partial folding; mediated by a complex of folding cofactors. |
| Major function | Folding of alpha- and beta-tubulin into assembly-competent heterodimers for microtubule formation. |
| Key cofactor | Tubulin folding cofactor A (TBCA), which binds beta-tubulin and is structurally conserved. |
| Cellular context | Cytoplasm; associated with chaperonin (CCT) and tubulin folding cofactor complexes. |
| Research relevance | Target for understanding microtubule biogenesis, cytoskeletal regulation, and disease mechanisms. |
What Is GO:0007023?
According to the Gene Ontology, GO:0007023 (post-chaperonin tubulin folding pathway) is defined as the completion of folding of alpha- and beta-tubulin; it takes place subsequent to chaperonin-mediated partial folding and is mediated by a complex of folding cofactors. In other words, after chaperonins provide an initial folding scaffold, a dedicated set of tubulin folding cofactors (such as TBCA, TBCB, TBCC, TBCD, and TBCE) interacts with tubulin polypeptides to achieve their final functional conformation. This process is a distinct biological process (ontology aspect: biological_process) and is essential for generating assembly-competent tubulin heterodimers.
Why Is post-chaperonin tubulin folding pathway Important in Cell Biology?
The post-chaperonin tubulin folding pathway is essential because it produces the functional alpha/beta-tubulin heterodimers required for microtubule assembly, which underpins cell division, intracellular transport, and cell shape. Defects in this pathway can impair microtubule dynamics and have been associated with disease states, including inflammatory and neurological conditions. Understanding the structural and biochemical basis of cofactor-mediated folding provides insights into fundamental cell biology and potential therapeutic targets.
• Provides assembly-competent alpha/beta-tubulin heterodimers for microtubule polymerization.
• Essential for mitotic spindle formation and chromosome segregation.
• Supports intracellular transport and maintenance of cell shape.
• Cofactor A (TBCA) is conserved from yeast to plants and humans, highlighting its fundamental role.
• Dysregulation of tubulin folding cofactors has been observed in sepsis-associated encephalopathy models.
• Structural studies of TBCA and Rbl2p provide a framework for understanding cofactor-tubulin interactions.
• The pathway is a potential target for cancer and neurodegenerative disease research.
• CRISPR-based models enable functional dissection of cofactor genes in this pathway.
What Happens During post-chaperonin tubulin folding pathway?
Chaperonin-mediated partial folding
In simple terms: Chaperonins help tubulin proteins start folding but do not finish the job.
Before the post-chaperonin pathway begins, alpha- and beta-tubulin polypeptides undergo partial folding assisted by chaperonins, particularly the chaperonin containing TCP-1 (CCT). This initial step provides a partially folded tubulin intermediate that is then handed off to the tubulin folding cofactor system.
Cofactor A binding to beta-tubulin
In simple terms: Cofactor A grabs beta-tubulin and keeps it stable for the next steps.
Tubulin folding cofactor A (TBCA) binds to beta-tubulin after chaperonin release. The crystal structure of the yeast cofactor A homolog Rbl2p revealed a dimeric alpha/beta fold that interacts with beta-tubulin, and the human TBCA structure confirmed a conserved architecture. This binding is thought to prevent premature aggregation and to facilitate subsequent folding steps.
Formation of the tubulin folding cofactor complex
In simple terms: Several cofactors work together as a team to finish folding tubulin.
The post-chaperonin pathway is mediated by a complex of folding cofactors, including TBCA, TBCB, TBCC, TBCD, and TBCE. These cofactors coordinate the folding of alpha- and beta-tubulin and their assembly into heterodimers. Structural and biochemical studies have begun to define the interactions among these cofactors and tubulin subunits.
Release of assembly-competent tubulin heterodimers
In simple terms: The final product is a ready-to-use tubulin pair for microtubules.
Upon completion of folding, the cofactor complex releases native alpha/beta-tubulin heterodimers that are competent for microtubule polymerization. This step is critical for maintaining the cellular pool of tubulin and for dynamic microtubule assembly.
Key Genes Involved in GO:0007023 post-chaperonin tubulin folding pathway
The following genes and proteins are central to the post-chaperonin tubulin folding pathway, based on verified structural and biochemical studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TBCA | Tubulin folding cofactor A; binds beta-tubulin and assists in folding | Structural studies of yeast and human TBCA reveal conserved beta-tubulin binding |
| RBL2P (yeast) | Yeast homolog of TBCA; binds beta-tubulin | Crystal structure solved, providing insights into cofactor function |
| TBCB | Tubulin folding cofactor B; part of the cofactor complex | Potential target for studying tubulin heterodimer assembly |
| TBCC | Tubulin folding cofactor C; involved in tubulin folding | May regulate the release of folded tubulin |
| TBCD | Tubulin folding cofactor D; participates in the cofactor complex | Linked to microtubule dynamics and disease |
| TBCE | Tubulin folding cofactor E; essential for tubulin folding | Mutations associated with neurodevelopmental disorders |
| CCT (chaperonin) | Chaperonin containing TCP-1; provides partial folding | Upstream of the post-chaperonin pathway |
| Alpha-tubulin | Substrate of the folding pathway | Final product is assembly-competent heterodimer |
| Beta-tubulin | Substrate of the folding pathway; binds TBCA | Central to microtubule formation |
| AtTBCA (Arabidopsis) | Plant homolog of TBCA; crystallized | Conservation across kingdoms |
| TBCA (human) | Human tubulin folding cofactor A | Three-dimensional structure determined |
| TBCA (yeast Rbl2p) | Yeast cofactor A homolog | Crystal structure of post-chaperonin beta-tubulin binding cofactor |
| Tubulin heterodimer | Product of the pathway | Building block of microtubules |
| Microtubule | Cellular structure assembled from tubulin heterodimers | Readout of pathway function |
| Sepsis-associated encephalopathy model | Inflammatory condition with altered tubulin folding gene expression | Rat model for studying neurological involvement |
| TBCA-related pathways | Cofactor-mediated folding | Target for CRISPR knockout studies |
| Tubulin folding cofactor complex | Multi-protein complex mediating folding | Biochemical reconstitution target |
| Chaperonin CCT | Initial folding of tubulin | Upstream regulator of the pathway |
How Is post-chaperonin tubulin folding pathway Regulated?
The post-chaperonin tubulin folding pathway is regulated at multiple levels, including the availability of chaperonins and the expression of tubulin folding cofactors. Cofactor A (TBCA) levels and its interaction with beta-tubulin are critical for efficient folding. In disease states such as sepsis-associated encephalopathy, altered expression of tubulin folding genes has been observed, suggesting inflammatory regulation. However, specific transcriptional or signaling regulators (e.g., mTOR, ISR) are not defined in the verified literature for this pathway.
post-chaperonin tubulin folding pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TBCA | Tubulin folding defects; potential link to neurodevelopmental disorders | CRISPR knockout in neuronal cell lines |
| TBCE | Neurodevelopmental disorders | Knock-in of patient mutations in iPSCs |
| TBCD | Microtubule dynamics; cancer | Overexpression in cancer cell lines |
| RBL2P (yeast) | Model for cofactor function | Yeast knockout and rescue |
| Tubulin folding genes | Sepsis-associated encephalopathy | Rat model of sepsis |
Sepsis-associated encephalopathy
In a rat model of sepsis-associated encephalopathy, mRNA and long non-coding RNA expression profiling revealed inflammatory features and altered expression of genes related to tubulin folding. This suggests that the post-chaperonin tubulin folding pathway may be impacted in neuroinflammatory conditions.
Cancer and microtubule dynamics
Because the pathway produces tubulin heterodimers for microtubule assembly, its dysregulation could affect cell division and contribute to cancer. However, direct evidence linking specific cofactor mutations to cancer is not provided in the verified citations.
Neurodevelopmental disorders
Tubulin folding cofactors such as TBCE are essential for proper tubulin function, and defects in tubulin folding have been associated with neurodevelopmental disorders. Structural insights into cofactor A may aid in understanding these conditions.
From post-chaperonin tubulin folding pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of TBCA loss on tubulin folding? | TBCA knockout cell line |
| How do point mutations in TBCA affect beta-tubulin binding? | Point mutation knock-in |
| Can wild-type TBCA rescue folding defects? | Knock-in of wild-type TBCA |
| Where does TBCA localize in cells? | Tagged knock-in (e.g., GFP-TBCA) |
| What happens when TBCA is overexpressed? | Overexpression cell line |
| Which cofactors interact with TBCA? | Proteomics and co-immunoprecipitation |
How to Study the post-chaperonin tubulin folding pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | Three-dimensional structure of cofactors | Structural basis of beta-tubulin binding |
| In vitro folding assays | Formation of tubulin heterodimers | Biochemical reconstitution |
| RNA-seq | mRNA and lncRNA expression changes | Disease model profiling |
| CRISPR knockout | Loss-of-function effects | Gene function studies |
| CRISPR knock-in | Point mutations or tags | Disease variant modeling |
| Overexpression | Gain-of-function effects | Cofactor dosage studies |
| Proteomics | Protein interactions | Cofactor complex composition |
| Immunofluorescence | Cellular localization | Tubulin network visualization |
Structural biology (X-ray crystallography)
X-ray crystallography has been used to determine the structures of yeast Rbl2p and human TBCA, revealing the fold and beta-tubulin binding interface. Crystallization of Arabidopsis TBCA also demonstrated conservation in plants.
Biochemical reconstitution
In vitro reconstitution assays with purified chaperonins and tubulin folding cofactors can measure the folding of alpha- and beta-tubulin into heterodimers.
Gene expression profiling
RNA-seq and lncRNA profiling in disease models, such as sepsis-associated encephalopathy, can identify changes in tubulin folding gene expression.
CRISPR-based functional genomics
CRISPR knockout, knock-in, and overexpression models enable causal testing of cofactor genes in the pathway.
How CRISPR Can Be Used to Study GO:0007023 post-chaperonin tubulin folding pathway
Knockout
CRISPR knockout of tubulin folding cofactor genes such as TBCA can reveal their essentiality for tubulin folding and microtubule assembly. Loss-of-function models help determine whether a cofactor is required for cell viability and proliferation.
Point Mutation
Introducing disease-associated point mutations into cofactor genes via CRISPR can test their impact on beta-tubulin binding and folding activity. Such models are valuable for understanding structural determinants of cofactor function.
Knock-in
Knock-in of tagged versions (e.g., GFP) of cofactors allows real-time imaging of their localization and dynamics in the post-chaperonin pathway. Knock-in of wild-type or mutant alleles can also rescue or exacerbate phenotypes.
Overexpression
CRISPR activation or cDNA overexpression of cofactors like TBCA can test whether increased dosage affects tubulin folding and microtubule dynamics. Overexpression models are useful for studying gain-of-function effects in disease.
How EDITGENE Supports post-chaperonin tubulin folding pathway Research
Researchers studying post-chaperonin tubulin folding pathway-related genes often need to determine whether a candidate gene is causally involved in tubulin folding, microtubule assembly, or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for post-chaperonin tubulin folding pathway research.
Frequently Asked Questions About post-chaperonin tubulin folding pathway
What is the post-chaperonin tubulin folding pathway?
It is the biological process (GO:0007023) that completes the folding of alpha- and beta-tubulin after chaperonin-mediated partial folding, mediated by a complex of tubulin folding cofactors.
What genes are involved in the post-chaperonin tubulin folding pathway?
Key genes include TBCA, TBCB, TBCC, TBCD, TBCE, and the chaperonin CCT, as well as alpha- and beta-tubulin themselves.
What is the role of TBCA in tubulin folding?
TBCA (tubulin folding cofactor A) binds beta-tubulin and assists in its folding; its structure is conserved from yeast to humans.
How is the post-chaperonin tubulin folding pathway studied?
It is studied using X-ray crystallography, biochemical reconstitution, RNA-seq, and CRISPR-based functional genomics.
What diseases are associated with defects in tubulin folding?
Dysregulation has been observed in sepsis-associated encephalopathy and has been linked to neurodevelopmental disorders and cancer.
What is the structure of tubulin folding cofactor A?
Crystal structures of yeast Rbl2p and human TBCA reveal a dimeric alpha/beta fold that binds beta-tubulin.
Is the post-chaperonin tubulin folding pathway conserved?
Yes, cofactor A is conserved across yeast, plants, and humans, indicating a fundamental role.
What happens if the post-chaperonin tubulin folding pathway is disrupted?
Disruption impairs the production of assembly-competent tubulin heterodimers, affecting microtubule dynamics and cell division.
Can CRISPR be used to study tubulin folding cofactors?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect cofactor function.
Where does the post-chaperonin tubulin folding pathway occur?
It occurs in the cytoplasm, following chaperonin-mediated partial folding.
Conclusion
The post-chaperonin tubulin folding pathway (GO:0007023) is a fundamental biological process that ensures alpha- and beta-tubulin attain their native, assembly-competent conformations through the action of a complex of tubulin folding cofactors. Structural and biochemical studies have illuminated the role of cofactor A and its conservation across species. Dysregulation of this pathway has been linked to inflammatory and neurological conditions, underscoring its disease relevance. Continued research using CRISPR-based models and advanced omics will further clarify the mechanisms and therapeutic potential of this pathway.
References
- 1. Steinbacher S. 1999. Crystal structure of the post-chaperonin beta-tubulin binding cofactor Rbl2p.. Nat Struct Biol 6(11):1029-32 PMID: 10542094
- 2. Guasch A et al.. 2002. Three-dimensional structure of human tubulin chaperone cofactor A.. J Mol Biol 318(4):1139-49 PMID: 12054808
- 3. Sun W et al.. 2017. mRNA and Long Non-coding RNA Expression Profiles in Rats Reveal Inflammatory Features in Sepsis-Associated Encephalopathy.. Neurochem Res 42(11):3199-3219 PMID: 28786048
- 4. Lu L et al.. 2010. Crystallization and preliminary X-ray analysis of tubulin-folding cofactor A from Arabidopsis thaliana.. Acta Crystallogr Sect F Struct Biol Cryst Commun 66(Pt 8):954-6 PMID: 20693679
